Hubei Zhongjian Medical Supplies Co., Ltd. – Trademark Portfolio

Entity Type: 99

Hubei Zhongjian Medical Supplies Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ZHONGJIAN MEDICAL. The owner is based in Xianning City,Hubei.

No. 20 Jincheng Avenue, Tiancheng Town

Chongyang County

Xianning City,Hubei 437599 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Hubei Zhongjian Medical Supplies Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Hubei Zhongjian Medical Supplies Co., Ltd. have?

Hubei Zhongjian Medical Supplies Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Hubei Zhongjian Medical Supplies Co., Ltd. file in?

Hubei Zhongjian Medical Supplies Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Hubei Zhongjian Medical Supplies Co., Ltd.'s most well-known trademarks?

Hubei Zhongjian Medical Supplies Co., Ltd.'s registered trademark portfolio includes well-known marks such as ZHONGJIAN MEDICAL. These are among 1 currently registered trademark in the portfolio.

What is Hubei Zhongjian Medical Supplies Co., Ltd.'s trademark registration success rate?

Hubei Zhongjian Medical Supplies Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.